Growth Metrics

Neurocrine Biosciences (NBIX) Interest & Investment Income (2016 - 2026)

Neurocrine Biosciences filings provide 16 years of Interest & Investment Income readings, the most recent being $25.8 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 14.67% to $25.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $90.3 million, a 0.77% decrease, with the full-year FY2025 number at $90.3 million, down 0.77% from a year prior.
  • Interest & Investment Income hit $25.8 million in Q4 2025 for Neurocrine Biosciences, up from $22.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $25.8 million in Q4 2025 to a low of $200000.0 in Q3 2022.
  • Median Interest & Investment Income over the past 5 years was $12.6 million (2023), compared with a mean of $12.2 million.
  • Biggest five-year swings in Interest & Investment Income: crashed 75.0% in 2021 and later skyrocketed 7150.0% in 2023.
  • Neurocrine Biosciences' Interest & Investment Income stood at $700000.0 in 2021, then soared by 85.71% to $1.3 million in 2022, then soared by 1353.85% to $18.9 million in 2023, then grew by 19.05% to $22.5 million in 2024, then grew by 14.67% to $25.8 million in 2025.
  • The last three reported values for Interest & Investment Income were $25.8 million (Q4 2025), $22.2 million (Q3 2025), and $20.6 million (Q2 2025) per Business Quant data.